Cancer-associated fibroblast compositions change with breast cancer progression linking the ratio of S100A4+ and PDPN+ CAFs to clinical outcome.
Friedman G, Levi-Galibov O, David E, Bornstein C, Giladi A, Dadiani M, Mayo A, Halperin C, Pevsner-Fischer M, Lavon H, Mayer S, Nevo R, Stein Y, Balint-Lahat N, Barshack I, Ali HR, Caldas C, Nili-Gal-Yam E, Alon U, Amit I, Scherz-Shouval R.
Friedman G, et al. Among authors: mayo a.
Nat Cancer. 2020 Jul;1(7):692-708. doi: 10.1038/s43018-020-0082-y. Epub 2020 Jun 29.
Nat Cancer. 2020.
PMID: 35122040